These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30940817)

  • 1. Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5
    Li Y; Tinoco R; Elmén L; Segota I; Xian Y; Fujita Y; Sahu A; Zarecki R; Marie K; Feng Y; Khateb A; Frederick DT; Ashkenazi SK; Kim H; Perez EG; Day CP; Segura Muñoz RS; Schmaltz R; Yooseph S; Tam MA; Zhang T; Avitan-Hersh E; Tzur L; Roizman S; Boyango I; Bar-Sela G; Orian A; Kaufman RJ; Bosenberg M; Goding CR; Baaten B; Levesque MP; Dummer R; Brown K; Merlino G; Ruppin E; Flaherty K; Ramer-Tait A; Long T; Peterson SN; Bradley LM; Ronai ZA
    Nat Commun; 2019 Apr; 10(1):1492. PubMed ID: 30940817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis.
    Fujita Y; Khateb A; Li Y; Tinoco R; Zhang T; Bar-Yoseph H; Tam MA; Chowers Y; Sabo E; Gerassy-Vainberg S; Starosvetsky E; James B; Brown K; Shen-Orr SS; Bradley LM; Tessier PA; Ronai ZA
    Cell Rep; 2018 Sep; 24(12):3296-3311.e6. PubMed ID: 30232010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors.
    Khateb A; Deshpande A; Feng Y; Finlay D; Lee JS; Lazar I; Fabre B; Li Y; Fujita Y; Zhang T; Yin J; Pass I; Livneh I; Jeremias I; Burian C; Mason JR; Almog R; Horesh N; Ofran Y; Brown K; Vuori K; Jackson M; Ruppin E; Deshpande AJ; Ronai ZA
    Nat Commun; 2021 Sep; 12(1):5397. PubMed ID: 34518534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Gut Microbiota Composition by Serotonin Signaling Influences Intestinal Immune Response and Susceptibility to Colitis.
    Kwon YH; Wang H; Denou E; Ghia JE; Rossi L; Fontes ME; Bernier SP; Shajib MS; Banskota S; Collins SM; Surette MG; Khan WI
    Cell Mol Gastroenterol Hepatol; 2019; 7(4):709-728. PubMed ID: 30716420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of the E3 ubiquitin ligase RNF5 is associated with decreased survival in breast cancer.
    Bromberg KD; Kluger HM; Delaunay A; Abbas S; DiVito KA; Krajewski S; Ronai Z
    Cancer Res; 2007 Sep; 67(17):8172-9. PubMed ID: 17804730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial Gut Microbial Composition as a Key Factor Driving Host Response to Antibiotic Treatment, as Exemplified by the Presence or Absence of Commensal Escherichia coli.
    Ju T; Shoblak Y; Gao Y; Yang K; Fouhse J; Finlay BB; So YW; Stothard P; Willing BP
    Appl Environ Microbiol; 2017 Sep; 83(17):. PubMed ID: 28667114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING.
    Yang LL; Xiao WC; Li H; Hao ZY; Liu GZ; Zhang DH; Wu LM; Wang Z; Zhang YQ; Huang Z; Zhang YZ
    Cell Death Dis; 2022 Oct; 13(10):889. PubMed ID: 36270989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newcastle Disease Virus V Protein Degrades Mitochondrial Antiviral Signaling Protein To Inhibit Host Type I Interferon Production via E3 Ubiquitin Ligase RNF5.
    Sun Y; Zheng H; Yu S; Ding Y; Wu W; Mao X; Liao Y; Meng C; Ur Rehman Z; Tan L; Song C; Qiu X; Wu F; Ding C
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31270229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions Between the Gut Microbiota and the Host Innate Immune Response Against Pathogens.
    Cheng HY; Ning MX; Chen DK; Ma WT
    Front Immunol; 2019; 10():607. PubMed ID: 30984184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ER-bound RING finger protein 5 (RNF5/RMA1) causes degenerative myopathy in transgenic mice and is deregulated in inclusion body myositis.
    Delaunay A; Bromberg KD; Hayashi Y; Mirabella M; Burch D; Kirkwood B; Serra C; Malicdan MC; Mizisin AP; Morosetti R; Broccolini A; Guo LT; Jones SN; Lira SA; Puri PL; Shelton GD; Ronai Z
    PLoS One; 2008 Feb; 3(2):e1609. PubMed ID: 18270596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease.
    Leber A; Hontecillas R; Tubau-Juni N; Zoccoli-Rodriguez V; Abedi V; Bassaganya-Riera J
    Front Immunol; 2018; 9():363. PubMed ID: 29535731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.
    Ekmekciu I; von Klitzing E; Fiebiger U; Neumann C; Bacher P; Scheffold A; Bereswill S; Heimesaat MM
    Front Cell Infect Microbiol; 2017; 7():167. PubMed ID: 28529928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Siah2 control of T-regulatory cells limits anti-tumor immunity.
    Scortegagna M; Hockemeyer K; Dolgalev I; Poźniak J; Rambow F; Li Y; Feng Y; Tinoco R; Otero DC; Zhang T; Brown K; Bosenberg M; Bradley LM; Marine JC; Aifantis I; Ronai ZA
    Nat Commun; 2020 Jan; 11(1):99. PubMed ID: 31911617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated ATF6 Induces Intestinal Dysbiosis and Innate Immune Response to Promote Colorectal Tumorigenesis.
    Coleman OI; Lobner EM; Bierwirth S; Sorbie A; Waldschmitt N; Rath E; Berger E; Lagkouvardos I; Clavel T; McCoy KD; Weber A; Heikenwalder M; Janssen KP; Haller D
    Gastroenterology; 2018 Nov; 155(5):1539-1552.e12. PubMed ID: 30063920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-33 Promotes REG3γ Expression in Intestinal Epithelial Cells and Regulates Gut Microbiota.
    Xiao Y; Huang X; Zhao Y; Chen F; Sun M; Yang W; Chen L; Yao S; Peniche A; Dann SM; Sun J; Golovko G; Fofanov Y; Miao Y; Liu Z; Chen D; Cong Y
    Cell Mol Gastroenterol Hepatol; 2019; 8(1):21-36. PubMed ID: 30831322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of Ubiquitin E3 Ligase RNF5 as a Novel Therapeutic Strategy in Neuroectodermal Tumors.
    Principi E; Sondo E; Bianchi G; Ravera S; Morini M; Tomati V; Pastorino C; Zara F; Bruno C; Eva A; Pedemonte N; Raffaghello L
    Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota Regulates Mincle Mediated Activation of Lung Dendritic Cells to Protect Against
    Negi S; Pahari S; Bashir H; Agrewala JN
    Front Immunol; 2019; 10():1142. PubMed ID: 31231363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotics-induced gut microbiota dysbiosis promotes tumor initiation via affecting APC-Th1 development in mice.
    Xu C; Ruan B; Jiang Y; Xue T; Wang Z; Lu H; Wei M; Wang S; Ye Z; Zhai D; Wang L; Lu Z
    Biochem Biophys Res Commun; 2017 Jun; 488(2):418-424. PubMed ID: 28506830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies.
    Jeon YJ; Khelifa S; Ratnikov B; Scott DA; Feng Y; Parisi F; Ruller C; Lau E; Kim H; Brill LM; Jiang T; Rimm DL; Cardiff RD; Mills GB; Smith JW; Osterman AL; Kluger Y; Ronai ZA
    Cancer Cell; 2015 Mar; 27(3):354-69. PubMed ID: 25759021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An IMD-like pathway mediates the intestinal immunity to modulate the homeostasis of gut microbiota in Rhynchophorus ferrugineus Olivier (Coleoptera: Dryophthoridae).
    Xiao R; Wang X; Xie E; Ji T; Li X; Muhammad A; Yin X; Hou Y; Shi Z
    Dev Comp Immunol; 2019 Aug; 97():20-27. PubMed ID: 30914318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.